This condition has distinct microscopic appearances allowing its differentiation from other ‘primary’ tauopathies, although the topographical distribution of the tau pathology is, to some extent, reminiscent of that seen in progressive supranuclear palsy (PSP). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.